The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia

Nature Communications

Volumn 6, Issue , 2015, Pages

  Liao, Jie ^a   Kapadia, Vishal S ^a   Brown, L Steven ^b   Cheong, Naeun ^a   Longoria, Christopher ^a   Mija, Dan ^a   Ramgopal, Mrithyunjay ^a   Mirpuri, Julie ^a   McCurnin, Donald C ^c   Savani, Rashmin C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; CD45 ANTIGEN; CRYOPYRIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; MYELOPEROXIDASE; PROTEIN P20; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; GLIBENCLAMIDE; IL1B PROTEIN, HUMAN; IL1B PROTEIN, MOUSE; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PEROXIDASE; SECRETORY IMMUNOGLOBULIN;

ABNORMALITY; DISEASE INCIDENCE; DISEASE TREATMENT; DRUG DEVELOPMENT; IMMUNE RESPONSE; NEONATE; PROTEIN; RESPIRATORY DISEASE; RODENT;

ADULT; ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BABOON; BIRTH WEIGHT; BONE MARROW DERIVED MACROPHAGE; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; EXPERIMENTAL MONKEY; FEMALE; GENE DELETION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; HYPEROXIA; INCIDENCE; INFANT; INFLAMMATION; LENGTH OF STAY; LUNG ALVEOLUS MACROPHAGE; LUNG DYSPLASIA; LUNG STRUCTURE; MOUSE; NEUTROPHIL; NEWBORN; NONHUMAN; ONTOGENY; OXYGEN CONCENTRATION; OXYGENATION; PATHOGENESIS; PHENOTYPE; PREMATURE LABOR; PREMATURITY; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHOALVEOLAR LAVAGE FLUID; COHORT ANALYSIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; PATHOLOGY; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS; PAPIO;

ACETYLGLUCOSAMINIDASE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPULMONARY DYSPLASIA; CARRIER PROTEINS; CASPASE 1; COHORT STUDIES; GLYBURIDE; HUMANS; HYPEROXIA; IMMUNOGLOBULIN A, SECRETORY; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMASOMES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; LUNG; MICE; MICE, KNOCKOUT; PAPIO; PEROXIDASE; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84948708402     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9977     Document Type: Article

References (52)

1. Jobe, A. H. The new bronchopulmonary dysplasia. Curr. Opin. Pediatr. 23, 167172 (2011).
2. Ryan, R. M., Ahmed, Q. & Lakshminrusimha, S. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin. Rev. Allergy Immunol. 34, 174-190 (2008).
3. Mosca, F., Colnaghi, M. & Fumagalli, M. BPD: old and new problems. J. Matern. Fetal Neonatal Med. 24(Suppl 1): 80-82 (2011).
4. Benko, S., Philpott, D. J. & Girardin, S. E. The microbial and danger signals that activate Nod-like receptors. Cytokine 43, 368-373 (2008).
5. Ye, Z. & Ting, J. P. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr. Opin. Immunol. 20, 3-9 (2008).
6. Sutterwala, F. S., Haasken, S. & Cassel, S. L. Mechanism of NLRP3 inflammasome activation. Ann. NY Acad. Sci. 19, 82-95 (2014).
7. Rindfleisch, M. S., Hasday, J. D., Taciak, V., Broderick, K. & Viscardi, R. M. Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J. Interferon Cytokine Res. 16, 365-373 (1996).
8. Hallegua, D. S. & Weisman, M. H. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann. Rheum. Dis. 61, 960-967 (2002).
9. Kakkera, D. K., Siddiq, M. M. & Parton, L. A. Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia. Biol. Neonate 87, 82-90 (2005).
10. Fukumoto, J. et al. NLRP3 deletion protects from hyperoxia-induced acute lung injury. Am. J. Physiol. Cell Physiol. 305, C182-C189 (2013).
11. Lamkanfi, M. et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol. 187, 61-70 (2009).
12. Coalson, J. J., Winter, V. & deLemos, R. A. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care. Med. 152, 640-646 (1995).
13. Coalson, J. J. et al. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 145, 872-881 (1992).
14. Onland, W. et al. Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study. BMC. Pediatr. 13, 207 (2013).
15. Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad. Sci. USA 110, 3507-3512 (2013).
16. Bhandari, V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res. A. Clin. Mol. Teratol. 100, 189-201 (2014).
17. Bose, C. L., Laughon, M. M. & Dammann, C. E. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch. Dis. Child Fetal Neonatal Ed. 93, F455-F461 (2008).
18. Speer, C. P. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin. Fetal Neonatal Med. 11, 354-362 (2006).
19. Chess, P. R., D'Angio, C. T., Pryhuber, G. S. & Maniscalco, W. M. Pathogenesis of bronchopulmonary dysplasia. Semin. Perinatol. 30, 171-178 (2006).
20. Watterberg, K. L. et al. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia. J. Pediatr. 125, 264-269 (1994).
21. Ogden, B. E., Murphy, S. A., Saunders, G. C., Pathak, D. & Johnson, J. D. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am. Rev. Respir. Dis. 130, 817821 (1984).
22. Rindfleisch, M. S., Hasday, J. D., Taciak, V., Boderick, K. & Viscardi, R. M. Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J. Interferon Cytokine Res. 16, 365-373 (1996).
23. Munshi, U. K., Niu, J. O., Siddiq, M. M. & Parton, L. A. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr. Pulmonol. 24, 331-336 (1997).
24. Becher, B. et al. High-dimensional analysis of the murine myeloid cell system. Nat. Immunol. 15, 1181-1189 (2014).
25. Petrilli, V., Dostert, C., Muruve, D. A. & Tschopp, J. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19, 615-622 (2007).
26. Goldbach-Mansky, R. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr. Rheumatol. Rep. 13, 123-131 (2011).
27. Goldfinger, S. The inherited autoinflammatory syndrome: a decade of discovery. Trans. Am. Clin. Climatol. Assoc. 120, 413-418 (2009).
28. Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397-411 (2013).
29. Broderick, L., De Nardo, D., Franklin, B. S., Hoffman, H. M. & Latz, E. The inflammasomes and autoinflammatory syndromes. Annu. Rev. Pathol. 10, 395-424 (2015).
30. Yoon, B. H. et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am. J. Obstet. Gynecol. 177, 825-830 (1997).
31. Ambalavanan, N. et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 123, 1132-1141 (2009).
32. Kotecha, S., Wilson, L., Wangoo, A., Silverman, M. & Shaw, R. J. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr. Res. 40, 250-256 (1996).
33. Lappalainen, U., Whitsett, J. A., Wert, S. E., Tichelaar, J. W. & Bry, K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am. J. Respir. Cell. Mol. Biol. 32, 311-318 (2005).
34. Bry, K., Whitsett, J. A. & Lappalainen, U. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am. J. Respir. Cell. Mol. Biol. 36, 32-42 (2007).
35. Bry, K., Hogmalm, A. & Backstrom, E. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia. Semin. Perinatol. 34, 211-221 (2010).
36. Sharma, A. A. et al. Impaired NLRP3 inflammasome activity during fetal development regulates IL-1beta production in human monocytes. Eur. J. Immunol. 45, 238-249 (2015).
37. Wu, J. et al. Activation of NLRP3 inflammasome in alveolar macrophages contributes to mechanical stretch-induced lung inflammation and injury. J. Immunol. 190, 3590-3599 (2013).
38. Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxininteracting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140 (2010).
39. Østerholt, H. C. et al. Antioxidant protects against increases in low molecular weight hyaluronan and inflammation in asphyxiated newborn pigs resuscitated with 100% oxygen. PLoS ONE 7, e38839 (2012).
40. Kone-Paut, I. & Galeotti, C. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome. Expert Rev. Clin. Immunol. 11, 1083-1092 (2015).
41. Goldbach-Mansky, R. et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med. 355, 581-592 (2006).
42. Krumm, B., Xiang, Y. & Deng, J. Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses. Protein Sci. 23, 526-538 (2014).
43. Nold, M. F. et al. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Proc. Natl Acad. Sci. USA 110, 14384-14389 (2013).
44. Hilgendorff, A., Reiss, I., Ehrhardt, H., Eickelberg, O. & Alvira, C. M. Chronic lung disease in the preterm infant. Lessons learned from animal models. Am. J. Respir. Cell Mol. Biol. 50, 233-245 (2014).
45. Nakanishi, H., Sugiura, T., Streisand, J. B., Lonning, S. M. & Roberts, Jr. J. D. TGF-betaneutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L151-L161 (2007).
46. Cooney, T. P. & Thurlbeck, W. M. The radial alveolar count method of Emery and Mithal: a reappraisal 1-postnatal lung growth. Thorax 37, 572-579 (1982).
47. Mithal, A. & Emery, J. L. The postnatal development of alveoli in premature infants. Arch. Dis. Child 36, 449-450 (1961).
48. Coalson, J. J. Experimental models of bronchopulmonary dysplasia. Biol. Neonate 71(Suppl 1): 35-38 (1997).
49. Coalson, J. J. Pathology of new bronchopulmonary dysplasia. Semin. Neonatol. 8, 73-81 (2003).
50. Coalson, J. J. Pathology of bronchopulmonary dysplasia. Semin. Perinatol. 30, 179-184 (2006).
51. Walsh, M. C., Wilson-Costello, D., Zadell, A., Newman, N. & Fanaroff, A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J. Perinatol. 23, 451-456 (2003).
52. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).